Skip to main content

Surgical Prioritisation


The COVID-19 pandemic was a global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The World Health Organisation (WHO) declared the outbreak a pandemic on 11th March 2020. As of 27 April 2024, the pandemic has caused 7,045,569[ confirmed deaths, making it the fifth-deadliest pandemic or epidemic in history. Our world in data

Surgical Prioritisation

The FSSA published and updated its guidance on surgical prioritisation 28th january 2020.

The FSSA updated its guidance  on 28th January 2022.

    This guidance also recommends that:

    • Elective surgical patients should have been pre-assessed, pre-habilitated as required and, ideally, fully vaccinated at least 2 weeks before their planned procedure. 
    • Patients on waiting lists shall be regularly reviewed to assess the need for re-prioritising.
    • General anaesthesia should be avoided for at least 7 weeks after Covid-19 infection.
    P1a   <24hrs Vascular injury or occlusion, Major haemorrhage, Ruptured AAA, Diabetic foot sepsis and Arterial thrombolysis for ALI
    P1b   <72hrs Acute on chronic limb ischaemia, Symptomatic carotid disease, Amputation (ALI/CLTI), venous thrombolysis for phlegmasia, Symptomatic AAA, and Acute Type B aortic dissection
    P2     <1mth

    Revascularisation for CLTI, AAA > 5.5cm and Diabetic foot surgery

    P3     <3mth  - 
    P4     Elective Varicose vein surgery, Thoracic outlet surgery, Claudication procedures and Uncomplicated AVM

    Resumption of Vascular Surgery

    GIRFT and the Vascular Society published guidance on resumption of services in June 2020.

    National Joint Vascular Implementation Board